U.S. pharmaceutical company Pfizer confirmed Friday it will temporarily reduce deliveries to Europe of its COVID-19 vaccine while it upgrades production capacity to 2 billion doses per year. “This temporary reduction will affect all European countries,” a spokeswoman for Pfizer…
Read More
Delaying second COVID-19 vaccine doses will make supplies last longer but comes with risks
During Pfizer-BioNTech’s vaccine trial, one vaccinated participant and nine who received a placebo developed a severe case of COVID-19 after the first dose. This suggests that participants developed partial protection as early as 12 days after the first dose. However,…
Read More
'Slower than expected': Covid vaccines not being given as quickly as projected
With only nine days to go, it’s unlikely the U.S. will meet the original goal of having 20 million people vaccinated by the end of the year, members of Operation Warp Speed said Wednesday. “That objective is unlikely to be…
Read More
Pfizer to supply US with additional 100M vaccines doses
Pfizer and BioNTech will supply the U.S. with an additional 100 million doses of their COVID-19 vaccine under a second agreement. The drugmakers said Wednesday that they expect to deliver all the doses by July 31. Pfizer already has a…
Read More
Pfizer and Moderna won’t be the only ones to reap huge payday
Pfizer and Moderna appear to be the clear leaders in the race for a COVID-19 vaccine. Pfizer has already begun distribution, and Moderna’s entry is on the brink of FDA approval, which would put the two at least weeks ahead…
Read More
BioNTech, Pfizer ask Europe to OK vaccine for emergency use
The German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for conditional approval of their coronavirus vaccine with the European Medicines Agency. The two companies said Tuesday that the submission, which occurred Monday, completes…
Read More
Pfizer Update On Our U.S. COVID-19 Vaccine Candidate Distribution Preparedness
NEW YORK, 16 November 2020 — Pfizer (NYSE: PFE) today announced the U.S. COVID-19 Immunization Pilot Program with four states, to help refine the plan for the delivery and deployment of the company’s COVID-19 vaccine candidate that is being co-developed with BioNTech. To build…
Read More
No Pfizer COVID-19 Vaccine Expected Before Election
MONDAY, Oct. 19, 2020 — Pfizer will not apply for emergency authorization of its COVID-19 vaccine before the third week in November, the company’s chief executive said in a statement posted to the Pfizer website on Friday. This is a…
Read More